Trial Profile
The Assesment of Thrombotic Markers Utilizing Ionic Versus Non-Ionic Contrast During Coronary Angiography and Intervention (AToMIC) Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 May 2019
Price :
$35
*
At a glance
- Drugs Iodixanol (Primary) ; Ioxaglate sodium (Primary) ; Bivalirudin
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms AToMIC
- 15 May 2015 New trial record